Amphetamine salt tablets recalled after bottles contained a lower strength tablet
Lannett mixed amphetamine salts tablets, 10 mg, lot 25283185A, are recalled because two bottles each contained one 5 mg tablet. 4,848 bottles are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported; a bottle containing a tablet of a different strength could lead to the wrong dose, and no injuries are reported.
Plain-English summary
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10 mg, in 100-tablet bottles and available on prescription only, distributed by Lannett Company, Inc. of Philadelphia, Pennsylvania, NDC 0527-0762-37, are being recalled. The affected product is lot 25283185A with an expiry of 02/28/2027, and the recall covers 4,848 bottles distributed in Ohio.
The recall was issued for the presence of a foreign tablet: two bottles labeled as the 10 mg product each contained one tablet of the 5 mg strength. The FDA classified the action as Class II.
Patients should check the lot number on their bottle against the recall and should ask their pharmacist before taking any tablet that does not match the expected appearance.
The recalled product
- Product
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE)
- Brand
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Manufacturer
- Lannett Company Inc.
- Category
- Drug — Central Nervous System
- Affected units
- 4,848
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot#: 25283185A. Expiry: 02/28/2027
Distribution
Distributed in 1 state:
Related recalls
Same brand · DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- HighTeva Amphetamine Tablets Recalled Due To Incorrect Strength Labeling
FDA (Drugs) · 2022-09-21
- HighTeva Recalls Mixed Amphetamine Salts Tablets Due to Mixed Strengths
FDA (Drugs) · 2020-06-10
- ModerateTeva Recalls Mixed Amphetamine Salts Tablets Due to Strength Variations
FDA (Drugs) · 2020-06-10
- ModerateTeva Recalls Mixed Strength Amphetamine Salts Tablets
FDA (Drugs) · 2020-06-10
- ModerateAurobindo Recalls Amphetamine Mixed Salts Tablets for Out-of-Specification Weight
FDA (Drugs) · 2019-10-23
Same manufacturer · Lannett Company Inc.
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateNiacin extended release tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-29
- HighLisdexamfetamine 40 mg bottles recalled after being filled with 30 mg capsules
FDA (Drugs) · 2025-09-03
Same hazard · foreign tablet
See all →- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- HighLisinopril and hydrochlorothiazide bottle contained a foreign antiretroviral tablet
FDA (Drugs) · 2025-07-23
- HighMetformin ER 500 mg tablets recalled due to foreign tablet contamination
FDA (Drugs) · 2025-01-15
- ModeratePregabalin Capsules Recalled Due to Foreign Tablet Contamination During Packaging
FDA (Drugs) · 2024-06-12
- HighIbuprofen and Famotidine Tablets Recalled for Foreign Tablet Contamination
FDA (Drugs) · 2024-01-24